Digestive Diseases and Sciences

, Volume 38, Issue 9, pp 1702–1711 | Cite as

ESWL and oral dissolution therapy

What factors influence results?
  • A. Buttmann
  • H. E. Adamek
  • J. Weber
  • J. F. Riemann
Original Articles


With the aim of identifying the criteria that have a decisive influence on the success of treatment of gallstones with ESWL and oral dissolution therapy, we investigated, in 117 patients, the stone-free rate as a function of sex, age, weight quotient, number of stones, total stone volume, and gallbladder function. The following inclusion criteria were applied: (1) the Munich criteria, (2) a follow-up period of at least 12 months, or (3) freedom from stones irrespective of the duration of the period of follow-up. Although, owing to the small number of cases involved, no significantly differing results were seen in the parameters investigated, clear tendencies were indeed observed. While age, sex, and weight quotient qppear to have no influence on the stone-free rate, the number of stones, total stone volume, and gallbladder function do appear to have an effect on the results of treatment. Patients with solitary stones not more than 20 mm in diameter, and patients with a small total stone volume and good gallbladder function would appear to have the best chance of becoming stone-free within a short period of time, irrespective of age, sex, or girth.

Key Words

extracorporeal shock wave lithotripsy ursodeoxycholic acid and chenodeoxycholic acid stonefree rate sex age weight quotient number of stones total stone volume gallbladder function 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ell C, Kerzel W, Heyder N, Günter E, Rödl W, Flügel H, Domschke W: Piezoelektrische Lithotripsie von Gallensteinen. Dtsch Med Wochenschr. 133:1503–1507, 1988Google Scholar
  2. 2.
    Greiner L, Wenzel H, Jakobeit C: Biliäre Stoßwellen-Lithotripsie. Dtsch Med Wochenschr. 133:1893–1896, 1988Google Scholar
  3. 3.
    Riemann JF, Adamek HE, Weber J: Die piezoelektrische Lithotripsie in der Behandlung von symptomatischen Gallensteinen. Med Klin 85:176–180, 1990Google Scholar
  4. 4.
    Sackmann M, Weber W, Delius M, et al: Extracorporeal shock wave lithotripsy of gallstones without general anesthesia; first clinical experience. Ann Intern Med 107:347–348, 1987Google Scholar
  5. 5.
    Halevy J: Management of cholesterol gallstones: Are there alternatives to cholecystektomy? J Intern Med 228:5–8, 1990Google Scholar
  6. 6.
    Rambow A, Staritz M, Klose P, Thelen M, Mz Büschenfelde KH: Extrakorporale Stosswellen-Lithotripsie von Gallenblasensteinen: Wieviele Patienten sind geeignet? Dtsch Med Wochenschr 114:895–898, 1989Google Scholar
  7. 7.
    Darzi A, Monson JRT, O'Morain C, Tanner WR, Keane FBW: Extension of selection criteria for extracorporeal shock wave lithotripsy for gallstones. Br Med J 298:302–303, 1989Google Scholar
  8. 8.
    Ell C, Kerzel W, Schneider HT, Benninger J, Wirtz P, Domschke W, Hahn EG: Piezoelectric lithotripsy: Stone disintegration and follow-up results in patients with symptomatic gallbladder stones. Gastroenterology 99:1439–1444, 1990Google Scholar
  9. 9.
    Greiner L, Jakobeit C: Biliary shock-wave lithotripsy: Experience of the first 3 years in 612 patients.In Gallstone Disease. W Swobodnik (ed). Heidelberg, Springer-Verlag, 1990, pp 177–193Google Scholar
  10. 10.
    Jakobeit Ch, Greiner L: Biliäre Stosswellenlithotripsie von Gallengangs- und Gallenblasensteinen-Bilanz von 3 Jahren: Ergebnisse-Erfahrungen-Erwartungen. Klin Wschr 68(suppl 19): 247, 1990 (abstract)Google Scholar
  11. 11.
    Mosnier H, Guivarc HM, Tyan P, Voinchet O: Treatment of calcified gallstones by piezoelectric lithoripsy (PEL). Gastroenterology 96:634, 1989 (abstract)Google Scholar
  12. 12.
    Sackmann M, Pauletzki J, Sauerbruch T, Holl J, Schelling G, Paumgartner G: The Munich gallbladder lithotripsy study: Results of the first 5 years with 711 patients. Ann Intern Med 114:290–296, 1991Google Scholar
  13. 13.
    Sackmann M, Delius M, Sauerbruch T, Holl J, Weber W, Ippisch E, Hagelauer U, Wess O, Hepp W, Brendl W, Paumgartner G: Shock-wave lithotripsy of gallbladder stones; the first 175 patients. N Engl J Med 318:393–397, 1988Google Scholar
  14. 14.
    Jeliffé DB: WHO Monogr. Ser. 53:3–5, 1966Google Scholar
  15. 15.
    Dodds WJ, Groh WJ, Darweesh RMA, Lawson TL, Kishk SMA, Kern MK: Sonographic measurement of gallbladder volume. Am J Radiol 145:1009–1010, 1985Google Scholar
  16. 16.
    Büchsel R, Matern S: Cholelithiasis. In: Klinik der Gegenwart, Gerok W, Hartmann F, Mertelsmann R, Phillip TM, Schuster H-P, Sybrecht GW (eds). Springer Verlag Heidelberg, Sonderdruck IV, 1990, p. 5Google Scholar
  17. 17.
    Capocaccia LB: Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO) The Epidemiology of Gallstone Disease in Rome; Italy. Part I, Prevalence Data in Men. Hepatology 8:904–906, 1988Google Scholar
  18. 18.
    Roda E: Factors associated with gallstone disease: observation in the “Sirmione Study.”In Epidemiology and Prevention of Gallstone Disease, L Capoccacccia, G Picci, M Angelica (eds). Lancester, MTP Press, 1984, pp 207–209Google Scholar
  19. 19.
    Roda E, Taroni F, Festi D: Gallstone disease: A clinical lesson from epidemiology. J Lithotr Stone Dis 2:279–288, 1990Google Scholar
  20. 20.
    Bennion LJ, Mott DM, Spangola AM: A Biochemical basis for the higher prevalence of cholesterol gallstones in women. Clin Res 26:496, 1978 (abstract)Google Scholar
  21. 21.
    Bennion LJ, Grundy SM: Risk factors for the development of cholelithiasis in man. Part II. N Engl J Med 299:1221–1221, 1978Google Scholar
  22. 22.
    Everson GT, McKinley C, Kern F: Mechanisms in gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest 87:273–246, 1991Google Scholar
  23. 23.
    Holstege A, Kohlberger EJ: Epidemiologie und Pathogenese von Gallensteinen. Fortschr Med 107:673–678, 1989Google Scholar
  24. 24.
    Niederau C, Strohmeyer G: Pathophysiologie der Bildung von Gallensteinrezidiven. Der Chirurg 61:359–364, 1990Google Scholar
  25. 25.
    Hikasa J, Nagase M, Tanimura H: Epidemiology and etiology of gallstones. Arch Jpn Surg 49:555–571, 1980Google Scholar
  26. 26.
    Janowitz P, Swobodnik W, Wechsler JG, Kuhn K, Ditschuneit H: Nukleationszeit und Alter bei Gallensteinpatienten. Z Gastrolenterol 28:571–573, 1990Google Scholar
  27. 27.
    Trotmann BW, Ostrow JD, Solaway RD: Pigment vs cholesterol cholelithiasis: Comparison of stone and bile composition. Am J Dig Dis 19:585–590, 1974Google Scholar
  28. 28.
    Sackmann M, Aydemir U, Pauletzki J, Hasford J, Sauerbruch T, Holl J, Paumgartner G: Factors determinating gallbladder clearance after shock wave therapy. Part 2. Hepatology 12:734, 1990 (abstract)Google Scholar
  29. 29.
    Glesson D, Ruppin CD, Saunders A, Murphy GM, Dowling RH: Final outcome of ursodesoxycholic treatment in 126 patients with radiolucent gallstones. Q J Med 76:711–729, 1990Google Scholar
  30. 30.
    Gordon SJ, Stampfl D, Taglienti G: Experience with gallbladder lithotripsy (GBL) in 100 patients: Factors affecting outcome. Part 2 Hepatology 12:868, 123, 1990 (abstract)Google Scholar
  31. 31.
    National Cooperative Gallstone Study Group: Chenodial (chenodecxycholic acid) for dissolution of gallstones. Ann Intern Med 95:257–282, 1981Google Scholar
  32. 32.
    Zuin M, Petroni ML, Grandinetti G, Crosignani A, Podda M: Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstones. Scand J Gastroenterol 26:257–262, 1991Google Scholar
  33. 33.
    Iser JH, Maton PN, Murphy GM, Dowling RH: Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gallstones. Br Med J 1:1509–1512, 1978Google Scholar
  34. 34.
    Chaussy C: Extracorporeal shock wave lithotripsy: New aspects in the treatment of kidney stone disease. Basel, Karger, 1982Google Scholar
  35. 35.
    Ponchon T, Barkum AN, Naouri A, Neidhard JP, Bouchet A: Extracorporeal biliary lithotripsy: The influence of tissues on the propagation of shock-waves. Gastroenterology 96:645, 1988 (abstract)Google Scholar
  36. 36.
    Albert MB, Fromm H: Extracorporeal shock-wave lithotripsy of gallstones with the adjuvant use of cholelitholytic bile acid. Semin Liver Dis 10:197–204, 1990Google Scholar
  37. 37.
    Schoenfield LJ, Berci PDG, Carnovale RL, I: The effect of ursodiol on the efficacy and safety of extracorporeal shockwave lithotripsy of gallstones: The Dornier National Biliary Lithotripsy Study. N Engl J Med 323:1239–1245, 1990Google Scholar
  38. 38.
    Ferruci JT: Biliary lithotripsy, 1989. Am J Roentgenol 153:15–22, 1989Google Scholar
  39. 39.
    Sauerbruch T, Schachler R, Bird NC, Frost E, Ross B, Sackmann M, Johnson AG, Paumgartner G: Extracorporeal shockwave lithotripsy (ESWL) of gallstones: Anin vitro comparison between an electrohydraulic and piezoceramic device. J Hepatol 9(suppl 1):220, 1989 (abstract)Google Scholar
  40. 40.
    Schneider HT, Ott R, Janowitz P, Swobodnik W, Neuhaus H, Ell C: Comparison of the electrohydraulic, electromagnetic and piezoelectric shock-wave principle: Anin vitro study with identical gallstones. Part 2. Gastroenterology 98:260, 1990 (abstract)Google Scholar
  41. 41.
    Zuin M, Grandinetti G, Bertolini E, Spinelli P, Mouttorsi W, Meroni E: Extracorporeal shock-wave-Lithotripsy (ESWL): Comparison of the efficacy of three machines. Ital J Gastroenterol 153:401, 1989Google Scholar
  42. 42.
    Darzi A, Carey PD, Monsen JRT, Tanner WA, Keane FBV: The influence of different shock wave and gallstones characteristics of fragmentation by extracorporeal shock wave lithotripsy (ESWL)—anin vitro study. Part 2. Gastroenterology 96:110, 1989 (abstract)Google Scholar
  43. 43.
    Darzi A, El-Sayed E, Tanner AD, Keane FBV: An analysis of the patients who failed to respond to combined gallstone lithotripsy and bile acid therapy. Part 2. Gastroenterology 98:580, 1990 (abstract)Google Scholar
  44. 44.
    Albert MB, Fromm H, Borstelmann R, Shehan CM, Gicking R: Successful outpatient treatment of gallstones with piezoelectric lithotripsy. Ann Intern Med 113:164–165, 1990Google Scholar
  45. 45.
    Sauerbruch T: Behandlung von Gallensteinen durch extrakorporale Stosswellen. Therapiewoche 39:3054–3056, 1989Google Scholar
  46. 46.
    Summerfield JA: Review article: Dissolution of gallstones in the biliary tree. Aliment Pharmacol Ther 3:211–221, 1989Google Scholar
  47. 47.
    Lanzini A, Facinetti D, Pigozzi G, Bettini L, Favagrossa GM, Muiesan G: Gallstone dissolution rate during cheno-and ursotherapy: Effect of bile acid-dose and cholesterol saturation index. Abstract, International Conference on Gallstones and their Management. Jerusalem, Israel, February 25–March 1, 1990Google Scholar
  48. 48.
    Ponchon T, Barkum AN, Pujol B, Mestas JL, Lambert R: Gallstone disappearance following extracorporeal lithotripsy and oral bile acid therapy. Gastroenterology 97:457–463, 1989Google Scholar
  49. 49.
    Albert MB, Fromm H: Piezoelectric lithotripsy and ursodeoxycholic acid (UDCA) treatment. Abstract: 102, Second International Meeting on Pathochemistry, Pathophysiology and Pathomechanics of the Biliary System and New Strategies for the Treatment of Hepato-Biliary Diseases, Bologna, Italy, March 19–21, 1990Google Scholar
  50. 50.
    Torres WE, Steinberg HV, Davis RC, Baumgartner BR, Nelson RC, Casarella WJ: Extracorporeal shock wave lithotripsy of gallstones: Results and 6-month follow up in 141 patients. Radiology 178:509–512, 1991Google Scholar
  51. 51.
    Darzi A, Leahy A, O'Morain C, Tanner WA, Keane FBV: Gallstone clearance: A randomized study of extracorporeal shock wave lithotripsy and chemical dissolutions. Br J Surg 77:1265–1267, 1990Google Scholar
  52. 52.
    Schneider HT, Günter E, Wentz B, Heyder B, Hahn EG, Ell C: Kontraktionskinetik der Gallenblase nach Gabe von Ceruletid und einer chemisch nicht definierten, physiologischen Reizmahlzeit. Ultrasch Klin Prax 5:108–112, 1990Google Scholar
  53. 53.
    Greiner L, Münks C, Heil W, Jackobeit C: Gallbladderstone fragments in feces after biliary extracorporeal shockwave-lithotripsy. Gastroenterology 98:1620–1624, 1990Google Scholar
  54. 54.
    Rothstein RP, Brugge WR, Dudley SL, Maler PF: Gallbladder motility on gallstone patients treated by extracorporeal shock-wave lithotripsy (ESWL) and ursocholic acid (URSO) or placebo. Part 2. Gastroenterology 98:259, 1990 (abstract)Google Scholar
  55. 55.
    Fisher RS, Stelzer F, Rock E, Trotman BW, Soloway RD, the American Gallstone Study Group: Abnormal gallbladder emptying in patients with gallstones. Am J Dig Dis 11:1019–1024, 1982Google Scholar
  56. 56.
    Fridhandler TM, Davidson JS, Shaffer EA: Defective gallbladder contractility in the ground squirrel and prairie dog during the early stages of gallstone formation. Gastroenterology 85:830–836, 1983Google Scholar
  57. 57.
    Lee SP, Maher K, Nicols JF: Origin and fate of biliary sludge. Gastroenterology 94:170–176, 1988Google Scholar
  58. 58.
    Spengler U, Sackmann T, Sauerbruch T, Holl J, Paumgärtner G: Gallbladder motility before and after extracorporeal shock wave lithotripsy. Gastroenterology 96:860–863, 1989Google Scholar

Copyright information

© Plenum Publishing Corporation 1993

Authors and Affiliations

  • A. Buttmann
    • 1
  • H. E. Adamek
    • 1
  • J. Weber
    • 1
  • J. F. Riemann
    • 1
  1. 1.Medizinische Klinik C (Gastroenterology and Hepatology)Klinikum der Stadt LudwigshafenLudwigshafenGermany

Personalised recommendations